Oseltamivir labels and packages

Jump to navigation Jump to search
Oseltamivir
TAMIFLU® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Labels And Packages

[1]

References

  1. ↑ "TAMIFLU (OSELTAMIVIR PHOSPHATE) POWDER, FOR SUSPENSION TAMIFLU (OSELTAMIVIR PHOSPHATE) CAPSULE [GENENTECH, INC.]". Retrieved 8 January 2014.

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Oseltamivir_labels_and_packages&oldid=928201"